pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›BIMATOPROST
drug · small molecule
save

BIMATOPROST

Phase 2updated 3mo ago
by $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 5
  • drugbimatoprost CR3 co-mentions · 3 sources
  • drugLumigan3 co-mentions · 3 sources
  • drugbimatoprost SR3 co-mentions · 3 sources
  • tagApproval2 co-mentions · 1 sources
  • tagRecall2 co-mentions · 2 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 8 investigational indications.

targets

Prostaglandin F2-alpha receptor

all catalysts(0)

nothing on the calendar yet

Trials studying BIMATOPROST

  • phase3Long-term Safety and Efficacy Extension Trial of Bimatoprost SRcompletedn=455
  • phase4Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Userecruitingn=20
  • phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)recruitingn=400
  • phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)recruitingn=400
  • N/AEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucomacompletedn=24
  • phase2Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solutionactive not recruitingn=201
  • phase3Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertensioncompletedn=515
  • phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)completedn=83
more trials →

News(0)

no news has mentioned this drug yet

brand
BIMATOPROST
trade names
Bimatoprost, Bimatoprost component of ganfort, Durysta, Latisse, Lumigan
generic
BIMATOPROST
MOA
12.1 Mechanism of Action Bimatoprost, a prostaglandin analog, is a synthetic structural analog of prostaglandin with ocular hypotensive activity. It selectively mimics the effects of naturally occurring substances, prostamides. Bimatoprost is believed to lower intraocular pressure (IOP) in humans by increasing outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes. Elevated IOP presents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.
indication
1 INDICATIONS AND USAGE Bimatoprost ophthalmic solution 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Bimatoprost ophthalmic solution 0.03% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. ( 1 )
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 21m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?